Price T Rowe Associates Inc Bio Rad Laboratories, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 27,620 shares of BIO stock, worth $9.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,620
Previous 45,350
39.1%
Holding current value
$9.5 Million
Previous $12.4 Million
25.38%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BIO
# of Institutions
458Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$656 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$533 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$448 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$374 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$245 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.47B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...